Literature DB >> 1856489

Culture-confirmed pneumonia due to Chlamydia pneumoniae.

J F Campbell1, R C Barnes, P E Kozarsky, J S Spika.   

Abstract

Diagnosis of infection caused by Chlamydia pneumoniae, a newly recognized respiratory pathogen, has proved difficult. Between July 1987 and April 1988, culture and serologic tests for C. pneumoniae were done on specimens from 49 patients with pneumonia seen at an Atlanta hospital emergency room. Cultures from 3 patients (6%) grew C. pneumoniae. Genus-specific Chlamydia complement fixation titers and microimmunofluorescence titers for C. pneumoniae were suggestive of acute infection in all 3 culture-positive patients. Three other patients had evidence of acute disease by published criteria for antibody titers. Most studies of C. pneumonia have not had culture-proven cases; the 6% rate of positive cultures in this study support the role of C. pneumoniae as a cause of pneumonia. More widespread availability of simplified culture systems for C. pneumoniae is needed. Caution should be used when interpreting serologic tests in the absence of culture confirmation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1856489     DOI: 10.1093/infdis/164.2.411

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Detection of Chlamydia pneumoniae in clinical specimens by polymerase chain reaction using nested primers.

Authors:  C M Black; P I Fields; T O Messmer; B P Berdal
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-09       Impact factor: 3.267

2.  Sézary T-cell activating factor is a Chlamydia pneumoniae-associated protein.

Authors:  J T Abrams; E C Vonderheid; S Kolbe; D M Appelt; E J Arking; B J Balin
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

3.  Chlamydia pneumoniae.

Authors:  T J Marrie
Journal:  Thorax       Date:  1993-01       Impact factor: 9.139

4.  Efficient culture of Chlamydia pneumoniae with cell lines derived from the human respiratory tract.

Authors:  K H Wong; S K Skelton; Y K Chan
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

5.  In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae.

Authors:  C C Kuo; L A Jackson; A Lee; J T Grayston
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

6.  Similarity of Chlamydia pneumoniae strains in the variable domain IV region of the major outer membrane protein gene.

Authors:  C A Gaydos; T C Quinn; L D Bobo; J J Eiden
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

7.  Acute lower respiratory tract infection associated with Chlamydia pneumoniae in Germany.

Authors:  C Jantos; P Artelt; H G Schiefer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-01       Impact factor: 3.267

8.  Isolation and characterization of a gene encoding a Chlamydia pneumoniae 76-kilodalton protein containing a species-specific epitope.

Authors:  M Perez Melgosa; C C Kuo; L A Campbell
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

9.  Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene.

Authors:  C A Gaydos; T C Quinn; J J Eiden
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

10.  Respiratory infection with Chlamydia pneumoniae in middle-aged and older adult outpatients.

Authors:  D H Thom; J T Grayston; L A Campbell; C C Kuo; V K Diwan; S P Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-10       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.